Raffles Medical GroupSGX:BSL -0.55%87 FCF Margin % is 10.15% as of Dec. 2025, which is 23% below its 10-year median of 13.15. GuruFocus rates SGX:BSL with a GF Score™ of 87/100 and a GF Value™ of S$1.05 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 667 Healthcare Providers & Services companies, Raffles Medical Group ranks better than 77.96% on this metric.
The historical rank and industry rank for Raffles Medical Group's FCF Margin % or its related term are showing as below:
SGX:BSL'
s FCF Margin % Range Over the Past 10 Years
Min: 2.43 Med: 13.15 Max: 23.68
Current: 11.93
During the past 13 years, the highest FCF Margin % of Raffles Medical Group was 23.68%. The lowest was 2.43%. And the median was 13.15%.
SGX:BSL's FCF Margin % is ranked better than 77.96% of 667
companies
in the Healthcare Providers & Services industry
Industry Median: 3.02
vs SGX:BSL: 11.93
Raffles Medical Group FCF Margin % Related Terms
Raffles Medical Group FCF Margin % Historical Data
* Premium members only.
The historical data trend for Raffles Medical Group's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Raffles Medical Group's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Raffles Medical Group FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Raffles Medical Group's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Raffles Medical Group's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Raffles Medical Group (SGX:BSL) has a FCF Margin % of 10.15% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Raffles Medical Group and its competitors. This is 23% below median its historical median of 13.15. Over the past decade, Raffles Medical Group's FCF Margin % has ranged from 2.43 to 23.68. According to the industry distribution chart, Raffles Medical Group ranks #147 out of 667 companies in the Healthcare Providers & Services industry, placing it in the top 22%.
Is Raffles Medical Group's FCF Margin % too high?
Raffles Medical Group's current FCF Margin % of 10.15% is 23% below median its 10-year median of 13.15. Over the past 10 years, this metric has ranged from a low of 2.43 to a high of 23.68. The Healthcare Providers & Services industry median FCF Margin % is 3.02. Raffles Medical Group's value of 10.15% is 236.1% above this industry median. Based on the distribution chart, Raffles Medical Group ranks #147 out of 667 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Raffles Medical Group has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Raffles Medical Group's FCF Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Raffles Medical Group ranks #147 out of 667 companies for FCF Margin %. This places Raffles Medical Group in the top 22% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 3.02. Raffles Medical Group's value of 10.15% is 236.1% above this benchmark. Historically, Raffles Medical Group's own FCF Margin % has ranged from 2.43 to 23.68 over the past decade. While the company's 10-year median is 13.15 vs. the industry median of 3.02, Raffles Medical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.02, based on 667 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Raffles Medical Group's current FCF Margin % of 10.15% is 236.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Raffles Medical Group and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Raffles Medical Group's current FCF Margin % is 10.15%, which is 23% below median its own 10-year median of 13.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raffles Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Raffles Medical Group (SGX:BSL) is currently considered Modestly Undervalued. The stock's GF Value™ is S$1.05, compared to a current price of S$0.91 — trading 13.3% below its estimated fair value. The current FCF Margin % is 10.15%, which is 23% below median its 10-year median of 13.15 and 236.1% above the Healthcare Providers & Services industry median of 3.02. Raffles Medical Group's overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Raffles Medical Group (SGX:BSL), the current FCF Margin % is 10.15% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Raffles Medical Group (SGX:BSL) Overvalued in 2026?
Based on GuruFocus' analysis, Raffles Medical Group stock appears to be undervalued.
The current stock price of S$0.91 is trading 13.3% below its estimated GF Value™ of S$1.05.
GuruFocus considers Raffles Medical Group to be Modestly Undervalued.
Key valuation signals for SGX:BSL:
FCF Margin %: 10.15% (23% below median its 10-year median of 13.15)
GF Value™: S$1.05 vs. price of S$0.91 (13.3% below fair value)
Industry Position: 236.1% above the Healthcare Providers & Services median (#147 of 667)
No single metric tells the full story. See the SGX:BSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Raffles Medical Group Ltd is an integrated private healthcare provider in Asia with operations in Singapore, China, Japan, Vietnam, and Cambodia. The company owns and operates a tertiary hospital, a network of medical and dental clinics, insurance services, Japanese and Traditional Chinese Medicine clinics, and a consumer healthcare division. The company's operating segment includes Healthcare services, Hospital Services, Investment Holdings, and Insurance Services. The company generates revenue from contracts with customers, Rental Income, and Insurance revenue. Geographically operates in Singapore, Greater China, Vietnam, Cambodia and Japan.
87GF Score
Get the complete analysis for SGX:BSL
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:BSL has been successfully added to your 
